Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years
 
  • Details

Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years

Journal
Journal of Hypertension
Journal Volume
35
Journal Issue
8
Pages
1698-1708
Date Issued
2017
Author(s)
VIN-CENT WU  
SHIH-CHIEH CHUEH  
Chen L.
Chang C.-H.
Hu Y.-H.
YEN-HUNG LIN  
KWAN-DUN WU  
WEI-SHIUNG YANG  
DOI
10.1097/HJH.0000000000001361
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017604508&doi=10.1097%2fHJH.0000000000001361&partnerID=40&md5=a0eb234d1e87cfe9f36fc82fadd3007f
https://scholars.lib.ntu.edu.tw/handle/123456789/515029
Abstract
Objective: Abnormal glucose metabolism due to insulin resistance has been linked to aldosterone overproduction. However, the long-term incidence of new-onset diabetes mellitus (NODM) among patients with primary aldosteronism after targeted treatment has not been well documented. Methods: The diagnosis of primary aldosteronism and essential hypertension were identified, and then the occurrence of NODM, all-cause mortality among these patients, was ascertained by a validated algorithm from a 23-million population insurance registry. Results: From 1999 to 2007, 2367 primary aldosteronism patients without previously diabetes mellitus were identified and propensity score-matched with 9468 patients with essential hypertension. Among those primary aldosteronism patients, 754 aldosterone-producing adenomas patients were identified and matched with 3016 essential hypertension controls. After a mean 5.2 years of follow-up, primary aldosteronism patients who underwent adrenalectomy had an attenuated NODM incidence (hazard ratio = 0.60, P < 0.01, versus essential hypertension); whereas those treated with mineralocorticoid receptor antagonist had augmented risk of NODM (hazard ratio = 1.16, P < 0.001, versus essential hypertension). Among the aldosterone-producing adenoma patients, adrenalectomy is also protective from developing NODM (hazard ratio = 0.61, P < 0.001, versus essential hypertension), however, mineralocorticoid receptor antagonist treatment did not alter the risk of NODM (P = 0.10, versus essential hypertension). Adjusted hazard ratios for long-term risk of mortality from this analysis revealed that adrenalectomy is protective, but NODM and major cardiovascular disease are deleterious. Conclusion: The primary aldosteronism patients who underwent adrenalectomy had reduced risk for incident NODM and all-cause of mortality, compared with matched hypertensive controls. This observation adds more evidence on the association of primary aldosteronism with a higher risk of metabolic syndrome and long-term mortality. ? 2017 Wolters Kluwer Health, Inc. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
alpha adrenergic receptor blocking agent; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; clopidogrel; dipeptidyl carboxypeptidase inhibitor; diuretic agent; histamine H2 receptor antagonist; hydroxymethylglutaryl coenzyme A reductase inhibitor; nitrate; proton pump inhibitor; serotonin uptake inhibitor; steroid; ticlopidine; uricosuric agent; warfarin; mineralocorticoid antagonist; adrenalectomy; adult; antihypertensive therapy; Article; cohort analysis; comorbidity; controlled study; diabetes mellitus; essential hypertension; female; follow up; hormonal therapy; human; hyperlipidemia; hyperuricemia; incidence; major clinical study; male; middle aged; mortality; mortality risk; new onset diabetes mellitus; primary hyperaldosteronism; priority journal; risk; complication; diabetes mellitus; diagnosis related group; hyperaldosteronism; hypertension; propensity score; risk factor; statistics and numerical data; Taiwan; Adrenalectomy; Diabetes Mellitus; Diagnosis-Related Groups; Female; Humans; Hyperaldosteronism; Hypertension; Incidence; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Propensity Score; Risk Factors; Taiwan
Publisher
Lippincott Williams and Wilkins
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science